Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Trial of the eyeWatch System as a First-Line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy

NCT04323930 is registered in ClinicalTrials.gov with Dr. Kaweh Mansouri as lead sponsor.

NCT NCT04323930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04323930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Trial of the eyeWatch System as a First-Line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy
Lead sponsor
Dr. Kaweh Mansouri
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2021
Completion date
December 31, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary glaucoma